With a bit of luck, soon there will be at least one antiviral pill that will reduce the impact for most sufferers of COVID-19. The pill might become available in Australia in the near future. A number of pharmaceutical companies are in discussions with the Federal Government about a new pre-purchase deal.
The drug being developed to treat people who have the COVID-19 virus is also capable of making those who are infected with it less contagious to others. People with severe COVID symptoms are being treated with a number of different drugs, and the new types of medicine should be incorporated in their treatment to help them. The majority of patients recover without medical attention, but in serious cases the virus spreads with such speed that it can create severe complications.
Although it’s not ready to be used yet, this drug is a significant step forward and could help prevent the spread of the virus. The two drugs used in Australian hospitals against COVID are Remdesivir and Dexamethasone. The first one does not allow COVID to replicate in the body, while the second one protects the immune system of the patient. Nevertheless, there is no at-home treatment. The government is now in the process of creating one.
Pfizer’s scientists are currently testing an antiviral pill to help people who are likely to progress into severe diseases. Scientists hope to have the new treatment ready by the end of the year. In addition to the already existing nasal spray vaccines, preventative spray antibodies are being tested for their ability to fight off the virus before it is able to enter the body. There are many different needs that COVID-19 can be treated for, and a large amount of research and development needs to be done into each.
